Innovent Biologics (PK)【IVBXF】銘柄情報

Innovent Biologics Inc (PK) (IVBXF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

9.96

( - )

買値

9.01

売値

10.01

出来高

0.00 日の範囲 0.00

9.10 52 週間の範囲 15.12

時価総額

17.313B

前日終値

9.96

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 13,258,095

発行済株式数

1,738,237,233

配当利回り

PER

139.75

1 株当たり利益 (EPS)

0.47

歳入

13.04B

純利益

813.57M

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal ant... Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 injection), mazdutide, PECONDLE (picankibart injection), and TABOSUN(Ipilimumab N01 injection). In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People’s Republic of China. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.innoventbio.com

本社

Suzhou, China

設立

2026

Innovent Biologics Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker IVBXF. The last closing price for Innovent Biologics (PK) was US$9.96. Over the last year, Innovent Biologics (PK) shares have traded in a share price range of US$ 9.10 to US$ 15.12.

Innovent Biologics (PK) currently has 1,738,237,233 shares in issue. The market capitalisation of Innovent Biologics (PK) is US$17.31 billion. Innovent Biologics (PK) has a price to earnings ratio (PE ratio) of 139.75.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0252	0.253653822925	9.9348	10.052	9.13	2294	9.63366994	CS
4	-0.11	-1.09235352532	10.07	11.334	9.1	9764	11.04889235	CS
12	-0.04	-0.4	10	12.35	9.1	8286	11.02689149	CS
26	-0.23	-2.25711481845	10.19	12.35	9.1	8912	10.44255944	CS
52	-0.44	-4.23076923077	10.4	15.12	9.1	29196	11.56294537	CS
156	5.97	149.62406015	3.99	15.12	3.55	66038	6.29565459	CS
260	-0.54	-5.14285714286	10.5	15.12	2.29	49759	6.37515053	CS